Liu, R.M., Aging, cellular senescence, and Alzheimer’s disease, Int. J. Mol. Sci., 2022, vol. 23, no. 4, p. 1989. https://doi.org/10.3390/ijms23041989

Article  CAS  PubMed  PubMed Central  Google Scholar 

Soria Lopez, J.A., González, H.M., and Léger, G.C., Alzheimer’s disease, Handb. Clin. Neurol., 2019, vol. 167, pp. 231–255. https://doi.org/10.1016/B978-0-12-804766-8.00013-3

Article  PubMed  Google Scholar 

Zagrebelsky, M., Tacke, C., and Korte, M., BDNF signaling during the lifetime of dendritic spines, Cell Tissue Res., 2020, vol. 382, pp. 185–199. https://doi.org/10.1007/s00441-020-03226-5

Article  PubMed  PubMed Central  Google Scholar 

Minichiello, L., TrkB signalling pathways in LTP and learning, Nat. Rev. Neurosci., 2009, vol. 10, pp. 850–860. https://doi.org/10.1038/nrn2738

Article  CAS  PubMed  Google Scholar 

Ibrahim, A.M., Chauhan, L., Bhardwaj, A., et al., Brain-derived neurotropic factor in neurodegenerative disorders, Biomedicines, 2022, vol. 10. https://doi.org/10.3390/biomedicines10051143

Allen, S.J., Watson, J.J., Shoemark, D.K., et al., GDNF, NGF and BDNF as therapeutic options for neurodegeneration, Pharmacol. Ther., 2013, vol. 138, pp. 155–175. https://doi.org/10.1016/j.pharmthera.2013.01.004

Article  CAS  PubMed  Google Scholar 

Invernizzi, S., Simoes Loureiro, I., Kandana Arachchige, K.G., and Lefebvre, L., Late-life depression, cognitive impairment, and relationship with Alzheimer’s disease, Dement. Geriatr. Cogn. Disord., 2022, vol. 50, pp. 414–424. https://doi.org/10.1159/000519453

Article  CAS  Google Scholar 

Roux, C.M., Leger, M., and Freret, T., Memory disorders related to hippocampal function: The interest of 5‑HT(4)Rs targeting, Int. J. Mol. Sci., 2021, vol. 22, no. 21, p. 12082. https://doi.org/10.3390/ijms222112082

Article  CAS  PubMed  PubMed Central  Google Scholar 

Nirogi, R., Jayarajan, P., Shinde, A., et al., Progress in investigational agents targeting serotonin-6 receptors for the treatment of brain disorders, Biomolecules, 2023, vol. 13, no. 2, p. 309. https://doi.org/10.3390/biom13020309

Article  CAS  PubMed  PubMed Central  Google Scholar 

Jiang, S., Sydney, E.J., Runyan, A.M., et al., 5-HT4 receptor agonists treatment reduces tau pathology and behavioral deficit in the PS19 mouse model of tauopathy, Preprint of bioRxiv Prepr. Serv. Biol., 2023. https://doi.org/10.1101/2023.02.03.526871

Labus, J., Röhrs, K.-F., Ackmann, J., et al., Amelioration of tau pathology and memory deficits by targeting 5-HT7 receptor, Prog. Neurobiol., 2021, vol. 197, p. 101900. https://doi.org/10.1016/j.pneurobio.2020.101900

Article  CAS  PubMed  Google Scholar 

Jahreis, K., Brüge, A., Borsdorf, S., et al., Amisulpride as a potential disease-modifying drug in the treatment of tauopathies, Alzheimers Dement., 2023. https://doi.org/10.1002/alz.13090

Popova, N.K. and Naumenko, V.S., Neuronal and behavioral plasticity: The role of serotonin and BDNF systems tandem, Expert Opin. Ther. Targets, 2019, vol. 23, pp. 227–239. https://doi.org/10.1080/14728222.2019.1572747

Article  CAS  PubMed  Google Scholar 

Homberg, J.R., Molteni, R., Calabrese, F., and Riva, M.A., The serotonin–BDNF duo: Developmental implications for the vulnerability to psychopathology, Neurosci. Biobehav. Rev., 2014, vol. 43, pp. 35–47. https://doi.org/10.1016/j.neubiorev.2014.03.012

Article  CAS  PubMed  Google Scholar 

Ilchibaeva, T., Tsybko, A., Zeug, A., et al., Serotonin receptor 5-HT2A regulates TrkB receptor function in heteroreceptor complexes, Cells, 2022, vol. 11. https://doi.org/10.3390/cells11152384

Stefanova, N.A., Muraleva, N.A., Korbolina, E.E., et al., Amyloid accumulation is a late event in sporadic Alzheimer’s disease-like pathology in nontransgenic rats, Oncotarget, 2015, vol. 6, pp. 1396–1413. https://doi.org/10.18632/oncotarget.2751

Article  PubMed  Google Scholar 

Stefanova, N.A., Maksimova, K.Y., Kiseleva, E., et al., Melatonin attenuates impairments of structural hippocampal neuroplasticity in OXYS rats during active progression of Alzheimer’s disease-like pathology, J. Pineal Res., 2015, vol. 59, pp. 163–177. https://doi.org/10.1111/jpi.12248

Article  CAS  PubMed  Google Scholar 

Rudnitskaya, E.A., Kolosova, N.G., and Stefanova, N.A., Impact of changes in neurotrophic supplementation on development of Alzheimer’s disease-like pathology in OXYS rats, Biochem., 2017, vol. 82, pp. 318–329. https://doi.org/10.1134/S0006297917030105

Article  CAS  Google Scholar 

Tyumentsev, M.A., Stefanova, N.A., Muraleva, N.A., et al., Mitochondrial dysfunction as a predictor and driver of Alzheimer’s disease-like pathology in OXYS rats., J. Alzheimers. Dis., 2018, vol. 63, pp. 1075–1088. https://doi.org/10.3233/JAD-180065

Article  CAS  PubMed  Google Scholar 

Kolosova, N.G., Stefanova, N.A., and Sergeeva, S.V., OXYS rats: A prospective model for evaluation of antioxidant availability in prevention and therapy of accelerated aging and age-related cognitive decline, in Handbook of Cognitive Aging: Causes, Processes and Effects (Aging Issues, Health and Financial Alternatives Series), 2011, ISBN 9781608760282.

Kulikov, A.V., Naumenko, V.S., Voronova, I.P., et al., Quantitative RT-PCR assay of 5-HT1A and 5-HT2A serotonin receptor MRNAs using genomic DNA as an external standard, J. Neurosci. Methods, 2005, vol. 141, p. 97–101. https://doi.org/10.1016/j.jneumeth.2004.06.005

Article  CAS  PubMed  Google Scholar 

Naumenko, V.S. and Kulikov, A.V., Quantitative assay of 5-HT1A receptor gene expression in the brain, Mol. Biol., 2006, vol. 40, p. 30–36. https://doi.org/10.1134/S0026893306010067/METRICS

Article  CAS  Google Scholar 

Naumenko, V.S., Osipova, D.V., Kostina, E.V., and Kulikov, A.V., Utilization of a two-standard system in real-time PCR for quantification of gene expression in the brain, J. Neurosci. Methods, 2008, vol. 170, pp. 197–203. https://doi.org/10.1016/j.jneumeth.2008.01.008

Article  CAS  PubMed  Google Scholar 

Gao, L., Zhang, Y., Sterling, K., and Song, W., Brain-derived neurotrophic factor in Alzheimer’s disease and its pharmaceutical potential, Transl. Neurodegener., 2022, vol. 11, pp. 1–34. https://doi.org/10.1186/s40035-022-00279-0

Article  CAS  Google Scholar 

Rudnitskaya, E.A., Maksimova, K.Y., Muraleva, N.A., et al., Beneficial effects of melatonin in a rat model of sporadic Alzheimer’s disease, Biogerontology, 2015, vol. 16, pp. 303–316. https://doi.org/10.1007/s10522-014-9547-7

Article  CAS  PubMed  Google Scholar 

Rudnitskaya, E.A., Kozlova, T.A., Burnyasheva, A.O., et al., Alterations of hippocampal neurogenesis during development of Alzheimer’s disease-like pathology in OXYS rats, Exp. Gerontol., 2019, vol. 115, pp. 32–45. https://doi.org/10.1016/j.exger.2018.11.008

Article  CAS  PubMed  Google Scholar 

Rudnitskaya, E.A., Kozlova, T.A., Burnyasheva, A.O., et al., Features of postnatal hippocampal development in a rat model of sporadic Alzheimer’s disease, Front. Neurosci., 2020, vol. 14, p. 533. https://doi.org/10.3389/fnins.2020.00533

Article  PubMed  PubMed Central  Google Scholar 

Stefanova, N.A., Muraleva, N.A., Maksimova, K.Y., et al., An antioxidant specifically targeting mitochondria delays progression of Alzheimer’s disease-like pathology, Aging (Albany, New York), 2016, vol. 8, p. 2713–2733. https://doi.org/10.18632/aging.101054

Article  CAS  Google Scholar 

Wang, Z.-H., Xiang, J., Liu, X., et al., Deficiency in BDNF/TrkB neurotrophic activity stimulates δ-secretase by upregulating C/EBPβ in Alzheimer’s disease, Cell Rep., 2019, vol. 28, pp. 655–669. https://doi.org/10.1016/j.celrep.2019.06.054

Article  CAS  PubMed  PubMed Central  Google Scholar 

Hosseini, S., Vázquez-Villegas, P., Rito-Palomares, M., and Martinez-Chapa, S.O., Enzyme-Linked Immunosorbent Assay (ELISA): From A to Z, 2018, Springer, 2018, ISBN 9789811067655.

Book  Google Scholar 

Lorke, D.E., Lu, G., Cho, E., and Yew, D.T., Serotonin 5-HT2A and 5-HT6 receptors in the prefrontal cortex of Alzheimer and normal aging patients, BMC Neurosci., 2006, vol. 7, рр. 1–8. https://doi.org/10.1186/1471-2202-7-36

Article  CAS  Google Scholar 

Yuede, C.M., Wallace, C.E., Davis, T.A., et al., Pimavanserin, a 5HT(2A) receptor inverse agonist, rapidly suppresses Aβ production and related pathology in a mouse model of Alzheimer’s disease, J. Neurochem., 2021, vol. 156, рр. 658–673. https://doi.org/10.1111/jnc.15260

Article  CAS  PubMed  PubMed Central  Google Scholar 

Solas, M., Van Dam, D, Janssens, J., et al., 5-HT(7) Receptors in Alzheimer’s disease, Neurochem. Int., 2021, vol. 150. https://doi.org/10.1016/j.neuint.2021.105185

Molobekova, C.A., Kondaurova, E.M., Ilchibaeva, T.V., et al., Amisulpride decreases tau protein hyperphosphorylation in the brain of OXYS rats, Curr. Alzheimer Res., 2023. https://doi.org/10.2174/1567205020666230828144651

Fidalgo, S., Ivanov, D.K., and Wood, S.H., Serotonin: From top to bottom, Biogerontology, 2013, vol. 14, pp. 21–45. https://doi.org/10.1007/s10522-012-9406-3

Article  CAS  PubMed  Google Scholar 

Madsen, K., Haahr, M.T., Marner, L., et al., Age and sex effects on 5-HT 4 receptors in the human brain: A 11 CSB207145 PET study, J. Cereb. Blood Flow Metab., 2011, vol. 31, p. 1475–1481. https://doi.org/10.1038/jcbfm.2011.11

Article  PubMed  PubMed Central  Google Scholar 

Rebholz, H., Friedman, E., and Castello, J., Alterations of expression of the serotonin 5-HT4 receptor in brain disorders, Int. J. Mol. Sci., 2018, vol. 19. https://doi.org/10.3390/ijms19113581

Zhang, X.X., Tian, Y., Wang, Z.T., et al., The epidemiology of Alzheimer’s disease modifiable risk factors and prevention, J. Prev. Alzheimer’s Dis., 2021, vol. 8, pp. 313–321. https://doi.org/10.14283/JPAD.2021.15

Article  Google Scholar